Overview
Aspect provides a digital health platform that supports women's hormonal health by combining continuous glucose monitoring (CGM) with AI-assisted coaching. Users receive a CGM device to track blood sugar and metabolism, and the platform analyzes this data to generate a personalized health plan with diet and exercise recommendations. A coach is available for guidance, and the entire service is offered via a subscription that includes access to the platform, the CGM device, and coaching. This setup differentiates Aspect through its focus on data-driven, personalized metabolism management specifically for conditions like PCOS, using continuous biometrics and AI coaching. The goal is to help women improve metabolic health and manage hormonal conditions by providing tailored guidance and ongoing support.
Work here?Claim your company
Simplify's take
What believers are saying
- Aspect updated its women's-health pages on October 27, 2026, signaling active product iteration.
- The company claims monthly CGM kits, AI insights, and board-certified coaches.
- Public profiles show a February 2025 raise and active investor backing.
What critics are saying
- BBB lists 12 complaints in three years, including one in the last twelve months.
- Google Play reviews complain cancellation fees and a broken cancellation process.
- Trustpilot rates Aspect 2.8 of 5, exposing retention risk and brand drag.
What makes Aspect unique
- Aspect's PCOS protocol pairs 14-day CGM, 1:1 coaching, and hormone-guided personalization.
- Its October 2026 site says Aspect is available in 49 states, excluding Kansas.
- Aspect markets OB-GYN-designed insulin-resistance care, not generic meal tracking.
Help us improve and share your feedback! Did you find this helpful?